Abstract

Mucormycosis is a life-threatening fungal infection caused by a group of molds called mucormycetes. Mucormycosis occurs in patients with less competent immune systems, including diabetes. Infected tissue is sent to a lab where it is cultured and examined under a microscope where doctors can diagnose the disease. As well, doctors do CT scans to check for damages to the facial structure. Treatment should be immediate and begin with high doses of intravenous antifungal medications such as amphotericin B, Isavuconazole or posaconazole. Surgery is required to remove infected tissue. To date, there are scant reports of the use of topical antifungal agents as an adjunct to surgery in the pediatric patient with cutaneous mucormycosis.